Clinical Research Program
The Clinical Research Program at BRI applies discoveries from the laboratory bench to the patient's bedside. This bench-to-bedside approach enables researchers to rapidly develop advancements in medical treatments with the potential to directly benefit patients living with disease. The Clinical Research Program supports and administers clinical research activities in arthritis, multiple sclerosis, cancer (breast, prostate, lung, colon, pancreatic and other sites), hepatitis, heart disease, diabetes and many other conditions. We have more than 55 Clinical Research Investigators involved in over 450 studies that enrolled over 5000 study participants last year. The Clinical Research Program supports our Investigator’s research efforts by offering centralized Study Coordinators and Assistants, oversight of regulatory and billing compliance, internal study audit and monitoring activities, training and education of all clinical research staff, contract and grant administration, Human Subjects protection and financial oversight.
To learn more about our clinical research, please visit our clinical trial website.
Clinical Research Program (CRP) includes:
- Christopher Porter, MD, Medical Director
- Cheryl Weaver, BA, CCRC, CCRA, Administrative Director
- Gail Chumbley, BS, CRP Specialist
This section provides information to research staff on the study submission process, tools, contact information, entering or changing a study listing and collecting data on ongoing study activities.
This section provides information for the patient and public to find a study, find resources and answers to frequently asked questions.
Clinical Research Units:
Cancer Clinical Research Unit
Clinical Trials Unit (Neurology, Cardiology, Anesthesiology)
Community Clinical Oncology Program (CCOP)
Diabetes Clinical Research Program
Digestive Disease Institute Clinical Research Unit
Nursing Clinical Research Unit